Dive Into Dollar Tr...
Health Care: Drugs
Clovis Oncology Inc (CLVS: NASDAQ)
$36.91 0.18 | 0.49%
05/17/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| CLVS | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 97.05 | 92.74 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | |
| Net Income | 0.00 | 0.00 | |
| EPS | 0.00 | 0.00 |
Earnings for CLVS:
| EBITDA | -69.00 |
| REVENUE | 0.00 |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.71 | $-0.69 | $-2.75 | $-3.21 |
| Number of Analysts | 2 | 2 | 3 | 2 |
| High Estimate | $-0.59 | $-0.60 | $-2.42 | $-2.86 |
| Low Estimate | $-0.84 | $-0.77 | $-3.11 | $-3.56 |
| Prior Year | $-0.61 | $-0.71 | $-2.86 | $-2.75 |
| Growth Rate (Year over Year) | -17.21% | 3.52% | 3.85% | -16.73% |
Portfolios with CLVS
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks With Big Insider Buy...
Latest CLVS Headlines from TheStreet
- 10 ASCO '13 Abstracts You Can Read Right Now 05.15.13 | 06:05 pm
- 4 Stocks Rising on Unusual Volume 05.08.13 | 09:05 pm
- 4 Stocks Spiking on Big Volume 04.10.13 | 02:04 pm
- Why This Fund Manager Is Short Ziopharm 03.22.13 | 07:03 am
- Celgene's Abraxane: Two Month Survival Boost In Pancreatic Cancer Trial 01.22.13 | 06:01 pm
- Nate Sadeghi's 2012 Biotech Stock Report Card 11.26.12 | 07:11 am
- Clovis Oncology: Pancreatic Cancer Drug Fails Late-Stage Test 11.12.12 | 05:11 am
- Celgene: Abraxane Boosts Pancreatic Cancer Survival 11.12.12 | 12:11 am
- 21 Most Volatile Biopharma Stocks Closing Out 2012 11.05.12 | 06:11 am
- Threshold's Pancreatic Cancer Drug May be Obsolete Before Launch 10.01.12 | 07:10 am
Press Releases for CLVS
- Clovis Oncology Announces 2012 Operating Results And 2013 Objectives - Business Wire 02.28.13 | 04:02 pm
- Clovis Oncology To Present At The Cowen Health Care Conference In Boston - Business Wire 02.25.13 | 04:02 pm
- Clovis Oncology To Announce Fourth Quarter/Year End 2012 Financial Results And Host Webcast Conference Call On February 28 - Business Wire 02.14.13 | 04:02 pm
- Clovis Oncology Announces 2013 Objectives And Financial Guidance - Business Wire 01.07.13 | 06:01 am
- Clovis Oncology To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 04:01 pm
- Clovis Oncology Announces Negative Outcome Of CO-101 In Pivotal LEAP Pancreatic Cancer Study - Business Wire 11.12.12 | 12:11 am
- Clovis Oncology To Present At The Credit Suisse Annual Healthcare Conference - Business Wire 11.08.12 | 05:11 pm
- Clovis Oncology Announces Third Quarter 2012 Operating Results - Business Wire 11.05.12 | 04:11 pm
- Clovis Oncology To Announce Third Quarter 2012 Financial Results And Host Webcast Conference Call On November 5 - Business Wire 10.18.12 | 04:10 pm
- Clovis Oncology To Present At September Conferences In Boston And New York - Business Wire 08.29.12 | 08:08 am
Partner Headlines for CLVS
- Pre-Market Most Active for Nov 12, 2012 : TIE, UN, BAC, GILD, MT, CLVS, FB, JEF, GRPN, DCM, NKTR, QQQ - NASDAQ 11.12.12 | 01:11 pm
- Investing in Biotech Stocks? The Journey to Profits Requires a Good GPS - NASDAQ 08.31.12 | 04:08 pm
- 5 Pharmaceutical Companies With Insider Buying During August 14-16 - Seeking Alpha 08.19.12 | 05:08 am
- Clovis Oncology Announces FDA Acceptance of Investigational New Drug Application for Oral EGFR Mutant-Selective Inhibitor CO-1686 - Benzinga 01.19.12 | 04:01 pm
- 15 Stocks Insiders Are Bullish About - Seeking Alpha 11.25.11 | 06:11 am
